Wang Lei, Cao Jian-Gang, Liu Jun
Department of Joint Surgery, Tianjin Hospital, Tianjin, People's Republic of China,
Department of Sport Medicine, Tianjin Hospital, Tianjin, People's Republic of China.
Ther Clin Risk Manag. 2019 Mar 14;15:487-495. doi: 10.2147/TCRM.S187979. eCollection 2019.
We conducted this meta-analysis to evaluate the efficacy of hybrid grafts in anterior cruciate ligament reconstruction (ACLR).
We performed an electronic search of the Cochrane Library, PubMed, Embase, and ScienceDirect from the inception of these databases to February 2018, based on the terms "anterior cruciate ligament or ACL reconstruction", "autograft", "hybrid", and "augment". Relevant journals and conference proceedings were searched manually. Quality assessment, data extraction, and calculation of data from the included studies were conducted independently by two reviewers using RevMan 5.1.
One randomized controlled trial and eight nonrandomized controlled trials met inclusion criteria. Larger graft diameters were found in the hybrid-graft group (mean difference -1.47, =0.0001). There was no significant difference in failure rate (OR 2.13, =0.21), retearing (OR 2.23, =0.12), revision of ACLR (OR 1.05, =0.87) or reoperation (OR 1.27, =0.35). Subgroup analysis showed that hybrid-graft patients with meniscus injury suffered more revision (OR 4.10, =0.02) and reoperation (OR 5.74, =0.001). Both autografts and hybrid grafts performed similarly in most knee-score systems. However, autograft patients had better KT-1000 (mean difference 0.24, =0.05) and quality-of-life results on the Knee Injury and Osteoarthritis Outcome Score measure (mean difference 7.23, =0.05).
This meta-analysis of the current literature indicates similar performance of hybrid or autologous grafts in ACLR, though hybrid grafts had larger diameters than autografts. Other potential factors to influence failure, revision, or postoperative knee function, such as irradiation, age at reconstruction, meniscus injury/treatment, and hybrid-graft remodeling, should be investigated further.
我们进行这项荟萃分析以评估混合移植物在前交叉韧带重建(ACLR)中的疗效。
基于“前交叉韧带或ACL重建”“自体移植物”“混合”和“增强”等术语,对Cochrane图书馆、PubMed、Embase和ScienceDirect从这些数据库创建至2018年2月进行电子检索。手动检索相关期刊和会议论文集。两名审阅者使用RevMan 5.1独立进行质量评估、数据提取以及纳入研究数据的计算。
一项随机对照试验和八项非随机对照试验符合纳入标准。混合移植物组的移植物直径更大(平均差值-1.47,P = 0.0001)。在失败率(比值比2.13,P = 0.21)、再撕裂率(比值比2.23,P = 0.12)、ACLR翻修率(比值比1.05,P = 0.87)或再次手术率(比值比1.27,P = 0.35)方面无显著差异。亚组分析表明,半月板损伤的混合移植物患者进行翻修(比值比4.10,P = 0.02)和再次手术(比值比5.74,P = 0.001)的情况更多。在大多数膝关节评分系统中,自体移植物和混合移植物的表现相似。然而,自体移植物患者在KT-1000测量中表现更好(平均差值0.24,P = 0.05),在膝关节损伤和骨关节炎转归评分测量中的生活质量结果也更好(平均差值7.23,P = 0.05)。
这项对当前文献的荟萃分析表明,在ACLR中混合移植物或自体移植物的表现相似,尽管混合移植物直径比自体移植物大。其他影响失败、翻修或术后膝关节功能的潜在因素,如放疗、重建时的年龄、半月板损伤/治疗以及混合移植物重塑,应进一步研究。